Clinical study
Screening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in The Netherlands

https://doi.org/10.1016/0002-9343(89)90296-9Get rights and content

Abstract

purpose: Identification of the hereditary non-polyposis colorectal carcinoma syndrome (HNPCC) is a basis for secondary prevention. The objectives of this study are to investigate the natural history of HNPCC and to assess the effect of screening.

patients and methods: Screening for colorectal carcinoma was performed in 22 HNPCC families (colonoscopy or double-contrast barium enema and sigmoidoscopy). The patients were subdivided into two groups. Group A comprised patients with colorectal cancer who were referred because they were symptomatic. Group B included family members of these patients who were found to have a colorectal lesion by screening. We compared these groups with respect to the stage of tumor growth.

results: Histologic examination of the tumors in Group A (87 patients) revealed Dukes A carcinomas in six patients, Dukes B carcinomas in 37, Dukes C carcinomas in 21, and Dukes D carcinomas in 10 patients (classification unknown in 13 patients). In Group B (20 patients), adenoma was found in 14 and carcinoma in six patients (Dukes A in two and Dukes B in four patients). A total of 93 patients, including those whose tumors were detected by screening, had a colorectal carcinoma. The age at diagnosis ranged from 24 to 81 years (mean age: 46 years). The location of the colonic tumors was proximal in 60 percent. Multiple primary tumors were found in 26 percent.

conclusion: These results suggest that screening leads to the early detection of colorectal carcinomas and adenomas in asymptomatic members of HNPCC families. Screening should be initiated at the age of 20 and continued during the life of the individual. Careful examination of the right colon is indicated because of the frequent occurrence of tumors in the proximal colon. A subtotal colectomy is indicated at the time of diagnosis of the initial colon cancer because of the risk of multiple primary tumors.

References (16)

There are more references available in the full text version of this article.

Cited by (137)

  • Molecular basis of diseases of the gastrointestinal tract

    2018, Molecular Pathology: The Molecular Basis of Human Disease
  • Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study

    2012, Surgery
    Citation Excerpt :

    In 1985, the Netherlands Foundation for Detection of Hereditary Tumours (NFDHT) started a registry of patients with FAP. The main objectives of this nationwide polyposis registry are coordination of lifelong surveillance of at-risk patients and promotion of early detection of cancer in high-risk families.29 Patients with FAP are referred to this national registry by gastroenterologists, surgeons, or clinical geneticists.

  • Risk and Epidemiological Time Trends of Gastric Cancer in Lynch Syndrome Carriers in The Netherlands

    2010, Gastroenterology
    Citation Excerpt :

    In the Netherlands, families with Lynch syndrome are registered at the nationwide Dutch Hereditary Cancer registry. A detailed description of the registry's approach has been described elsewhere.12 Briefly, families suspected for Lynch syndrome are referred by specialists and genetic centers to the registry from all parts of the Netherlands.

  • Sebaceous lesions and their associated syndromes: Part II

    2009, Journal of the American Academy of Dermatology
    Citation Excerpt :

    Key points For patients with Lynch syndrome, intensive cancer screening has been shown to lead to the detection of colorectal cancers at an earlier stage than historical controls.123,148-156 It is likely that patients with MTS would also benefit from the same intensive screening as Lynch syndrome patients.

View all citing articles on Scopus
View full text